254 related articles for article (PubMed ID: 32130675)
1. The epidemiology of NAFLD in Mainland China with analysis by adjusted gross regional domestic product: a meta-analysis.
Wu Y; Zheng Q; Zou B; Yeo YH; Li X; Li J; Xie X; Feng Y; Stave CD; Zhu Q; Cheung R; Nguyen MH
Hepatol Int; 2020 Mar; 14(2):259-269. PubMed ID: 32130675
[TBL] [Abstract][Full Text] [Related]
2. Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: a systematic review and meta-analysis.
Ye Q; Zou B; Yeo YH; Li J; Huang DQ; Wu Y; Yang H; Liu C; Kam LY; Tan XXE; Chien N; Trinh S; Henry L; Stave CD; Hosaka T; Cheung RC; Nguyen MH
Lancet Gastroenterol Hepatol; 2020 Aug; 5(8):739-752. PubMed ID: 32413340
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of fatty liver disease and the economy in China: A systematic review.
Zhu JZ; Zhou QY; Wang YM; Dai YN; Zhu J; Yu CH; Li YM
World J Gastroenterol; 2015 May; 21(18):5695-706. PubMed ID: 25987797
[TBL] [Abstract][Full Text] [Related]
4. Global incidence of non-alcoholic fatty liver disease: A systematic review and meta-analysis of 63 studies and 1,201,807 persons.
Le MH; Le DM; Baez TC; Wu Y; Ito T; Lee EY; Lee K; Stave CD; Henry L; Barnett SD; Cheung R; Nguyen MH
J Hepatol; 2023 Aug; 79(2):287-295. PubMed ID: 37040843
[TBL] [Abstract][Full Text] [Related]
5. Unexpected Rapid Increase in the Burden of NAFLD in China From 2008 to 2018: A Systematic Review and Meta-Analysis.
Zhou F; Zhou J; Wang W; Zhang XJ; Ji YX; Zhang P; She ZG; Zhu L; Cai J; Li H
Hepatology; 2019 Oct; 70(4):1119-1133. PubMed ID: 31070259
[TBL] [Abstract][Full Text] [Related]
6. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes.
Younossi ZM; Koenig AB; Abdelatif D; Fazel Y; Henry L; Wymer M
Hepatology; 2016 Jul; 64(1):73-84. PubMed ID: 26707365
[TBL] [Abstract][Full Text] [Related]
7. The epidemiology of NAFLD and lean NAFLD in Japan: a meta-analysis with individual and forecasting analysis, 1995-2040.
Ito T; Ishigami M; Zou B; Tanaka T; Takahashi H; Kurosaki M; Maeda M; Thin KN; Tanaka K; Takahashi Y; Itoh Y; Oniki K; Seko Y; Saruwatari J; Kawanaka M; Atsukawa M; Hyogo H; Ono M; Ogawa E; Barnett SD; Stave CD; Cheung RC; Fujishiro M; Eguchi Y; Toyoda H; Nguyen MH
Hepatol Int; 2021 Apr; 15(2):366-379. PubMed ID: 33580453
[TBL] [Abstract][Full Text] [Related]
8. Prevalence, incidence, and outcome of non-alcoholic fatty liver disease in Asia, 1999-2019: a systematic review and meta-analysis.
Li J; Zou B; Yeo YH; Feng Y; Xie X; Lee DH; Fujii H; Wu Y; Kam LY; Ji F; Li X; Chien N; Wei M; Ogawa E; Zhao C; Wu X; Stave CD; Henry L; Barnett S; Takahashi H; Furusyo N; Eguchi Y; Hsu YC; Lee TY; Ren W; Qin C; Jun DW; Toyoda H; Wong VW; Cheung R; Zhu Q; Nguyen MH
Lancet Gastroenterol Hepatol; 2019 May; 4(5):389-398. PubMed ID: 30902670
[TBL] [Abstract][Full Text] [Related]
9. Epidemiology of lean/non-obese nonalcoholic fatty liver disease in China: A systematic review and meta-analysis.
Zhang J; Huang X; Dong L; Yang Y; Kong D
Saudi Med J; 2023 Sep; 44(9):848-863. PubMed ID: 37717964
[TBL] [Abstract][Full Text] [Related]
10. Global epidemiology of lean non-alcoholic fatty liver disease: A systematic review and meta-analysis.
Lu FB; Zheng KI; Rios RS; Targher G; Byrne CD; Zheng MH
J Gastroenterol Hepatol; 2020 Dec; 35(12):2041-2050. PubMed ID: 32573017
[TBL] [Abstract][Full Text] [Related]
11. NASH/Liver Fibrosis Prevalence and Incidence of Nonliver Comorbidities among People with NAFLD and Incidence of NAFLD by Metabolic Comorbidities: Lessons from South Korea.
Park J; Lee EY; Li J; Jun MJ; Yoon E; Ahn SB; Liu C; Yang H; Rui F; Zou B; Henry L; Lee DH; Jun DW; Cheung RC; Nguyen MH
Dig Dis; 2021; 39(6):634-645. PubMed ID: 33535211
[TBL] [Abstract][Full Text] [Related]
12. The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: A systematic review and meta-analysis.
Younossi ZM; Golabi P; de Avila L; Paik JM; Srishord M; Fukui N; Qiu Y; Burns L; Afendy A; Nader F
J Hepatol; 2019 Oct; 71(4):793-801. PubMed ID: 31279902
[TBL] [Abstract][Full Text] [Related]
13. The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis.
Riazi K; Azhari H; Charette JH; Underwood FE; King JA; Afshar EE; Swain MG; Congly SE; Kaplan GG; Shaheen AA
Lancet Gastroenterol Hepatol; 2022 Sep; 7(9):851-861. PubMed ID: 35798021
[TBL] [Abstract][Full Text] [Related]
14. Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016-2030.
Estes C; Anstee QM; Arias-Loste MT; Bantel H; Bellentani S; Caballeria J; Colombo M; Craxi A; Crespo J; Day CP; Eguchi Y; Geier A; Kondili LA; Kroy DC; Lazarus JV; Loomba R; Manns MP; Marchesini G; Nakajima A; Negro F; Petta S; Ratziu V; Romero-Gomez M; Sanyal A; Schattenberg JM; Tacke F; Tanaka J; Trautwein C; Wei L; Zeuzem S; Razavi H
J Hepatol; 2018 Oct; 69(4):896-904. PubMed ID: 29886156
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of nonalcoholic fatty liver disease in mainland of China: a meta-analysis of published studies.
Li Z; Xue J; Chen P; Chen L; Yan S; Liu L
J Gastroenterol Hepatol; 2014 Jan; 29(1):42-51. PubMed ID: 24219010
[TBL] [Abstract][Full Text] [Related]
16. Burden of liver complications related to non-alcoholic fatty liver disease in China from 2005 to 2019: Observations from the Global Burden of Disease Study, 2019.
Liu H; Qi J; Yang J; Liu F; Li X; Yin P; Wang L; Liang Z; Wei L; Rao H; Zhou M
Diabetes Obes Metab; 2023 Apr; 25 Suppl 1():43-52. PubMed ID: 36781698
[TBL] [Abstract][Full Text] [Related]
17. Identification of reciprocal causality between non-alcoholic fatty liver disease and metabolic syndrome by a simplified Bayesian network in a Chinese population.
Zhang Y; Zhang T; Zhang C; Tang F; Zhong N; Li H; Song X; Lin H; Liu Y; Xue F
BMJ Open; 2015 Sep; 5(9):e008204. PubMed ID: 26395497
[TBL] [Abstract][Full Text] [Related]
18. Risk factors and metabolic abnormality of patients with non-alcoholic fatty liver disease: Either non-obese or obese Chinese population.
Lee SW; Lee TY; Yang SS; Tung CF; Yeh HZ; Chang CS
Hepatobiliary Pancreat Dis Int; 2018 Feb; 17(1):45-48. PubMed ID: 29428103
[TBL] [Abstract][Full Text] [Related]
19. [Prevalence of nonalcoholic fatty liver disease and metabolic abnormalities in 387 obese children and adolescents in Beijing, China].
Zhou X; Hou DQ; Duan JL; Sun Y; Cheng H; Zhao XY; Liu JT; Yang P; Shan XY; Mi J
Zhonghua Liu Xing Bing Xue Za Zhi; 2013 May; 34(5):446-50. PubMed ID: 24016432
[TBL] [Abstract][Full Text] [Related]
20. Prevalence, characteristics and mortality outcomes of obese, nonobese and lean NAFLD in the United States, 1999-2016.
Zou B; Yeo YH; Nguyen VH; Cheung R; Ingelsson E; Nguyen MH
J Intern Med; 2020 Jul; 288(1):139-151. PubMed ID: 32319718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
